Answers are grounded in this paper and cite their sources.
The purpose of this article is to investigate how organizations organize the early phases of research and development (R&D) projects in the pharmaceutical industry to achieve frequent innovation. The investigation was designed as a qualitative multiple case study. The analysis identified a standardized projectification of the preproject phases, leading to certain conflicts, such as a severe tension between dynamic, project, and multiproject capabilities, which hamper frequent innovation. Optimizing combinative capabilities to balance the capabilities triumvirate can provide powerful leverage and boost frequent innovation.
No takes yet. Share an insight, caveat, or question.
Thomas Biedenbach (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: